The new inhaled insulin, Exubera, is getting patients excited

The new inhaled insulin, Exubera, is getting patients excited.

Some may try to get it early from across the border...when it comes out later this summer in the U.S.

It will be an alternative to short-acting mealtime insulin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote